Lion Point Capital’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$649K	Hold	46,300	–	–	4.41%	12
2025 Q1	$724K	Hold	46,300	–	–	4.62%	10
2024 Q4	$645K	Buy	46,300 +11,200	+32%	+$156K	3.38%	16
2024 Q3	$326K	Buy	+35,100	New	+$326K	0.73%	18